York Pharma PLC - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for York Pharma PLC Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

York Pharma PLC. The Group's principal activity is acquiring, developing and commercialising prescription dermatological products. It focuses on a dermatological product called abafungin, a topical therapy intended for the treatment of fungal infections and some mixed microbial infections. The Group's product will be marketed under the trade mark Abasol. The Group's other product brands are Sabarep and Vampex. The Group operates in the United Kingdom, Japan and Germany.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report